FDA Adverse Event Injury Summary report: N

SIENTRA SILICONE GEL BREAST IMPLANTS

MDR report key: 23190880 · Received October 1, 2025

Report

Report Number
1651189-2025-09565
Event Type
Injury
Date Received
October 1, 2025
Date of Event
September 26, 2025
Report Date
September 26, 2025
Manufacturer
TIGER AESTHETICS MEDICAL
Product Code
FTR
PMA / PMN Number
P070004
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
KS, US
Reporter Occupation
NURSE
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

TIGER AESTHETICS MEDICAL COMPLAINT #: (B)(4). DEVICE EVALUATION: D6B, D9, G3, G6, H2, H3, H6, H10. TIGER AESTHETICS MEDICAL RECEIVED THE SUSPECTED DEVICE FROM THE CUSTOMER AND PERFORMED A FAILURE ANALYSIS. THE DEVICE WAS RETURNED INTACT AND FUNCTIONAL WITH CREASES AND MODERATE YELLOWING. THE DEVICE WEIGHED 286.3 GRAMS. NO ADDITIONAL OBSERVATIONS. TIGER AESTHETICS MEDICAL WILL SUBMIT A SUPPLEMENTAL REPORT IN ACCORDANCE WITH 21 CFR SECTION 803.56 IF ADDITIONAL INFORMATION BECOMES AVAILABLE.

Additional Manufacturer Narrative · 0

TIGER AESTHETICS MEDICAL COMPLAINT #: (B)(4). ADDITIONAL INFORMATION: H6. TIGER AESTHETICS MEDICAL WILL SUBMIT A SUPPLEMENTAL REPORT IN ACCORDANCE WITH 21 CFR SECTION 803.56 IF ADDITIONAL INFORMATION BECOMES AVAILABLE. B5.

Additional Manufacturer Narrative · 0

TIGER AESTHETICS MEDICAL COMPLAINT #: (B)(4). AT THIS TIME, THE SUSPECT DEVICE HAS NOT BEEN RETURNED FOR EVALUATION. TIGER AESTHETICS MEDICAL WILL SUBMIT A SUPPLEMENTAL REPORT IN ACCORDANCE WITH 21 CFR SECTION 803.56 IF ADDITIONAL INFORMATION BECOMES AVAILABLE.

Description of Event or Problem · 0

RIGHT-SIDE CAPSULAR CONTRACTURE BAKER GRADE 3 AND RIGHT-SIDE CREASE DISCOVERED DURING SURGERY. DATE EVENT FOR CREASE: 11/11/2025.

Description of Event or Problem · 0

RIGHT-SIDE CAPSULAR CONTRACTURE BAKER GRADE 3.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1659512 SIENTRA SILICONE GEL BREAST IMPLANTS SILICONE GEL BREAST IMPLANT FTR TIGER AESTHETICS MEDICAL 10512-XXXMP A39736

Patients

Seq Age Sex Outcome Treatment
1 71 YR Female Required Intervention